Frist Cressey Ventures is a healthcare-focused venture capital firm that invests in early-stage technology and services businesses. Their strategy is to partner with innovative companies aiming to transform healthcare by improving care quality, patient outcomes, system efficiency, accessibility, and affordability, with a recent emphasis on AI-native business models.
Portfolio
9
Fund Size
$1B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Thyme Care | Series B | $60M | Aug 2023 |
| Visana Health | Seed | $10.1M | Aug 2023 |
| DexCare | Series C | $75M | Jun 2023 |
| DexCare, Inc. | Series C | $75M | Jun 2023 |
| Psych Hub | Series B | $16M | Aug 2022 |
| Memora Health | Growth | $40M | Feb 2022 |
| DexCare | Series B | $50M | Jan 2022 |
| DexCare | Series A | $20M | Mar 2021 |
| Hint Health | Series B | $45M | — |
Top Co-Investors
Kaiser Permanente Ventures4 shared
SpringRock Ventures4 shared
Transformation Capital4 shared
AlleyCorp2 shared
Providence Ventures2 shared
Iconiq Capital2 shared
Foresite Capital1 shared
Casdin Capital1 shared
HC9 Ventures1 shared
Emerson Collective1 shared
Andreessen Horowitz1 shared
Mass General Brigham Ventures1 shared
Flare Capital Partners1 shared
Last updated: 3 March 2026